{"id":"https://openalex.org/keywords/cyp2c19-3","display_name":"CYP2C19*3","description":"CYP2C19*3 is a loss-of-function variant of the CYP2C19 gene, relevant to pharmacogenetic differences in drug metabolism and treatment response.","display_name_alternatives":["CYP2C19 *3","CYP2C19 star 3","CYP2C19*3 allele","rs4986893","CYP2C19 636G>A","CYP2C19 c.636G>A","CYP2C19 W212X"],"ids":{"openalex":"https://openalex.org/keywords/cyp2c19-3","wikidata":null},"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.6256,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.6256,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.2952,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"works_count":508,"cited_by_count":8074,"works_api_url":"https://api.openalex.org/works?filter=keywords.id:keywords/cyp2c19-3","updated_date":"2026-11-18T04:07:20","created_date":"2026-09-30T00:00:00"}
